CYP3A5 EXPRESSION IN HUMAN ENTEROCYTES

被引：0

作者：

JANARDAN, SK ^{[1
]}

LOWN, KS ^{[1
]}

GHOSH, M ^{[1
]}

KOLARS, JC ^{[1
]}

WATKINS, PB ^{[1
]}

机构：

[1] UNIV MICHIGAN,DEPT MED,ANN ARBOR,MI 48109

来源：

GASTROENTEROLOGY | 1994年 / 106卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A241 / A241

页数：1

共 50 条

[11] In vitro metabolism of cyclosporine A by human kidney CYP3A5 [J].

Dai, Y ;

Iwanaga, K ;

Lin, YS ;

Hebert, MF ;

Davis, CL ;

Huang, WL ;

Kharasch, ED ;

Thummel, KE .

BIOCHEMICAL PHARMACOLOGY, 2004, 68 (09) :1889-1902

[12] CYP3A5 phenotyping of human liver microsomes with vincristine [J].

Dennison, Jennifer B. ;

Jones, David R. ;

Renbarger, Jamie L. ;

Hall, Stephen D. .

DRUG METABOLISM REVIEWS, 2006, 38 :210-210

[13] In vitro and in vivo analysis of the human cyp3a5 promoter [J].

Nem, D. ;

Qiu, H. ;

Nestler, S. ;

Goedtel-Armbrust, U. ;

Wojnowski, L. .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 :88-88

[14] Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics [J].

Fröhlich, M ;

Hoffmann, MM ;

Burhenne, J ;

Mikus, G ;

Weiss, J ;

Haefeli, WE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) :443-444

[15] PharmVar GeneFocus: CYP3A5 [J].

Rodriguez-Antona, Cristina ;

Savieo, Jessica L. ;

Lauschke, Volker M. ;

Sangkuhl, Katrin ;

Drogemoller, Britt, I ;

Wang, Danxin ;

Schaik, Ron N. H. ;

Gilep, Andrei A. ;

Peter, Arul P. ;

Boone, Erin C. ;

Ramey, Bronwyn E. ;

Klein, Teri E. ;

Whirl-Carrillo, Michelle ;

Pratt, Victoria M. ;

Gaedigk, Andrea .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) :1159-1171

[16] Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism [J].

Westlind-Johnsson, A ;

Malmebo, S ;

Johansson, A ;

Otter, C ;

Andersson, TB ;

Johansson, I ;

Edwards, RJ ;

Boobis, AR ;

Ingelman-Sundberg, M .

DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) :755-761

[17] Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43 [J].

Krusekopf, S ;

Roots, I ;

Kleeberg, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 466 (1-2) :7-12

[18] In vitro metabolism of cyclosporine A by human kidney microsomal CYP3A5 [J].

Dai, Y ;

Iwanaga, K ;

Lin, YS ;

Huang, W ;

Thummel, KE .

DRUG METABOLISM REVIEWS, 2003, 35 :188-188

[19] Variability in Expression of CYP3A5 in Human Fetal Liver (vol 43, pg 1286, 2015) [J].

Vyhlidal, C. A. ;

Pearce, R. E. ;

Gaedigk, R. ;

Calamia, J. C. ;

Shuster, D. L. ;

Thummel, K. E. ;

Leeder, J. S. .

DRUG METABOLISM AND DISPOSITION, 2016, 44 (09) :1459-1459

[20] Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes [J].

Dennison, Jennifer B. ;

Mohutsky, Michael A. ;

Barbuch, Robert J. ;

Wrighton, Steven A. ;

Hall, Stephen D. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (01) :248-257

← 1 2 3 4 5 →